Drug Discovery World

MARCH 27, 2024

The vaccines currently in late-stage development hold promise in tackling the disease burden of tuberculosis (TB), says data and analytics company GlobalData on World Tuberculosis Day 2024. According to GlobalData, there are 11 vaccines in late-stage development for TB globally. TB remains a global pandemic, with 1.8

Vaccine 130

Vaccine Clinical Trials Licensing Licensing 130

Drug Discovery World

SEPTEMBER 18, 2023

Next generation Covid-19 vaccines could have the potential to expand the breadth of coverage against existing and future variants of the virus, extend the duration of protection, and offer better protection in the prevention of illness and transmission over the current state of vaccine technologies.

Clinical Trials 130

Clinical Trials Vaccine Trials Government 130

Drugs.com

FEBRUARY 2, 2024

2, 2024 -- In some good news for those folks who rolled up their sleeves for the latest COVID vaccine last fall, new government research shows the updated shots halve the chances of getting a symptomatic infection.“Everything FRIDAY, Feb. Everything from.

Vaccine 96

Vaccine Government Research 96

Drugs.com

DECEMBER 15, 2023

15, 2023 -- Low vaccination rates for the flu, RSV and COVID-19 are putting Americans at higher risk for severe illness and hospitalization this winter, a new government alert warned Thursday.There is an “urgent need” to boost. FRIDAY, Dec.

Vaccine 115

Vaccine Government Hospitals 115

Drugs.com

NOVEMBER 10, 2023

10, 2023 (Healthday News) -- In a sign that suggests many American parents have become dubious about the safety of childhood vaccines, new government data shows that immunization exemptions for kindergartners have reached their highest. FRIDAY, Nov.

Vaccine 101

Vaccine Government 101

The Pharma Data

JANUARY 27, 2021

Government to Increase Vaccine Deliveries to States. 27, 2021 — In response to COVID-19 vaccine shortages, the U.S. Vaccine shortages have forced some vaccination sites across the country to cancel tens of thousands of appointments. Professional. WEDNESDAY, Jan. The administration plans to make about 10.1

Government 52

Government Vaccine Disease 52

Drug Discovery World

DECEMBER 22, 2022

Shelley McLendon , SVP of Vaccine and Infectious Diseases Program Management at ICON, attended the World Vaccine Congress Europe from 16-19 October 2022 in Barcelona, Spain. Key learnings by countries and governments from Covid-19 . Some countries do seem to have learned the importance of disease surveillance.

Vaccine 130

Vaccine Disease Clinical Trials Trials 130

The Pharma Data

DECEMBER 19, 2020

government’s public-private partnership to deliver COVID-19 vaccines to Americans, and under the direction of the Centers for Disease Control and Prevention (CDC) , McKesson began distributing Moderna’s COVID-19 vaccines and the ancillary supply kits needed to administer them. government. Photo: Business Wire).

Government 52

Government Vaccine Pharmacy Pharmaceuticals 52

The Pharma Data

JULY 11, 2021

government’s decision to donate an initial 12 million doses of the Company’s COVID-19 vaccine through the COVAX Facility. will allocate a second tranche of Johnson & Johnson COVID-19 vaccines to additional lower-income countries. government, Johnson & Johnson and Gavi, the Vaccine Alliance. government.

Government 52

Government Vaccine 52

Drug Discovery World

FEBRUARY 6, 2024

The Association of the British Pharmaceutical Industry (ABPI) has published a manifesto outlining what a UK government must do to make the country a great place to research and develop the medicines and vaccines of the future.

Science 130

Science Government Vaccine Pharmaceuticals 130

Drugs.com

MARCH 28, 2024

THURSDAY, March 28, 2024 -- Mpox cases are climbing again in the United States, with the number of reported infections now twice as high as they were at this time last year, new government data shows.In response, public health experts have raised.

Vaccine 120

Vaccine Government 120

The Pharma Data

OCTOBER 28, 2021

GOVERNMENT AN Fresh 50 MILLION PEDIATRIC Boluses OF COVID-19 VACCINE TO SUPPORT Farther PREPAREDNESS FOR FUTURE NEEDS. government has bought 50 million further boluses of the companies’COVID-19 vaccine. government has exercised its final purchase option under its beingU.S. PFIZER AND BIONTECH TO GiveU.S.

Government 52

Government Vaccine Clinical Trials FDA 52

The Pharma Data

JUNE 25, 2021

Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the U.S. government has purchased an additional 200 million doses of Moderna’s COVID-19 vaccine, including the option to purchase other COVID-19 vaccine candidates from Moderna’s pipeline.

Government 40

Government Vaccine RNA Science 40

The Pharma Data

JULY 23, 2021

government has purchased an additional 200 million doses of the Pfizer-BioNTech COVID-19 Vaccine. government under its existing supply agreement to 500 million. government with 500 million doses of the companies’ COVID-19 vaccine for donation to the world’s poorest nations. This press release features multimedia.

Vaccine 52

Vaccine Government Immune Response FDA 52

The Pharma Data

AUGUST 31, 2020

Johnson & Johnson Announces Agreement in Principle with Government of Canada to Supply its COVID-19 Vaccine Candidate. Johnson & Johnson Announces Agreement in Principle with Government of Canada to Supply its COVID-19 Vaccine Candidate. S vaccine candidate on a not-for-profit basis for emergency pandemic use.

Government 52

Government Vaccine Pharmaceutical Companies Regulations 52

Drug Discovery World

JANUARY 9, 2023

It is hoped that a new partnership between the UK government and BioNTech will help accelerate clinical trials of personalised immunotherapies for cancer and infectious disease vaccines. . The agreement means cancer patients will get early access to trials exploring personalised mRNA therapies, like cancer vaccines. .

Research 130

Research Vaccine Government Clinical Trials 130

The Pharma Data

JUNE 24, 2021

government to purchase at not-for-profit price 200 million doses in 2021 and 300 million in the first half of 2022. Effort is part of the companies’ recent pledge of two billion doses to ensure global equitable access to the vaccine. NEW YORK & MAINZ, Germany–(BUSINESS WIRE)– Pfizer Inc. Our partnership with the U.S.

Government 52

Government Vaccine Clinical Trials Licensing 52

The Pharma Data

AUGUST 14, 2020

The UK Government has signed a new deal with Johnson & Johnson and Novavax to secure 90 million orders of their vaccine candidates to protect against COVID-19 infection. . S, the COVID-19 vaccine candidate developed by Janssen, the pharmaceutical subsidiary of J&J, for not-for-profit emergency pandemic use.

Government 52

Government Vaccine Clinical Trials Pharmaceuticals 52

The Pharma Data

AUGUST 5, 2020

Government for 100 Million Doses of Investigational COVID-19 Vaccine. Government for 100 Million Doses of Investigational COVID-19 Vaccine. Company working to ensure broad global access to COVID-19 vaccine candidate, following approval from regulators. Johnson & Johnson Announces Agreement with U.S.

Government 52

Government Vaccine Pharmaceutical Companies Regulations 52

The Pharma Data

OCTOBER 21, 2020

More than two dozen researchers and experts have penned a letter to HHS Secretary Alex Azar, National Institutes of Health (NIH) officials and pharma company executives, imploring them to shed more light on the clinical trial designs for federally funded COVID-19 vaccine studies. Source link.

Vaccine 52

Vaccine Government Trials Research 52

Drug Discovery World

DECEMBER 19, 2023

The programme, curated by DDW and sponsored by Integra Biosciences and Hamamatsu Corporation, will feature leading research from experts in academia, government agencies and industry on how technology is innovating from bench to bedside.

Vaccine 162

Vaccine Engineering Government Drug Development 162

Drug Discovery World

DECEMBER 6, 2023

The UK government has published new terms for the Statutory Scheme for branded medicines, which controls the prices of medicines paid by the NHS. Exemptions from payment will be implemented for medicines containing a new active substance, exceptional central procurements and centrally procured vaccines. in 2024, 24% in 2025 and 26.8%

Government 147

Government Pharma Companies Science International 147

Drug Discovery World

JUNE 9, 2023

UQ Vice-Chancellor Professor Deborah Terry said the Brisbane-Atlanta partnership will bring together world-class researchers to accelerate the development of vaccines to help deliver commercial and public health outcomes. The post Brisbane-Atlanta partnership focuses on pandemic response appeared first on Drug Discovery World (DDW).

Vaccine 130

Vaccine Clinical Trials Virus Government 130

The Pharma Data

AUGUST 13, 2020

The UK government has signed deals for a further 90 million doses of coronavirus vaccine. The vaccines are being developed by the Belgian pharmaceutical company Janssen and the US biotech company Novavax. It means the UK has placed orders for six experimental vaccines, taking its potential stockpile to 340 million doses.

Vaccine 52

Vaccine Virus Government Clinical Trials 52

The Pharma Data

OCTOBER 28, 2020

OSAKA, Japan–( BUSINESS WIRE )– Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK), announced today that it will import and distribute 50 million doses of Moderna’s COVID-19 vaccine candidate, mRNA-1273, starting in the first half of 2021, pending licensure in Japan. President of the Global Vaccine Business Unit, Takeda.

Government 40

Government Vaccine Pharmaceutical Companies Pharmaceuticals 40

Drugs.com

SEPTEMBER 30, 2023

29, 2023 – When pregnant women get a COVID vaccine, it helps protect their newborns from the virus, a new government study shows. These findings indicate that maternal vaccination during pregnancy could help prevent. FRIDAY, Sept.

Vaccine 115

Vaccine Virus Government 115

The Pharma Data

AUGUST 5, 2020

Company working to ensure broad global access to COVID-19 vaccine candidate, following approval from regulators. government for the large scale domestic manufacturing and delivery in the U.S. of 100 million doses of Janssen’s SARS-CoV-2 investigational vaccine, Ad26.COV2.S, NEW BRUNSWICK, N.J., NEW BRUNSWICK, N.J.,

Government 40

Government Vaccine Pharmaceutical Companies Regulations 40

The Pharma Data

NOVEMBER 12, 2020

billion Operation Warp Speed vaccine contract in a Securities and Exchange Commission (SEC) filing this week, ending speculation about the details. Novavax published its entire $1.6 Source link.

Vaccine 40

Vaccine Government Research 40

Drug Target Review

FEBRUARY 15, 2024

To survive this era, governments, multi-lateral organisations, foundations, and industry will need to work collectively on researching and developing new drugs that can prevent or treat a broad range of epidemic-prone pathogens, some of which have not yet been identified. Vaccines, however, do have some critical limitations.

Drug Development 121

Drug Development Virus Vaccine Government 121

Drug Discovery World

APRIL 10, 2023

India is traditionally known as ‘the pharmacy of the world’ due to its huge pharmaceuticals manufacturing capacity and high quantity of exports, particularly generic medicines and vaccines. Hyderabad is recognised as the vaccine hub of India. Genome Valley provides an estimated one-third of children’s vaccines globally.

Vaccine 130

Vaccine Pharmaceuticals Drugs Science 130

Drug Discovery World

SEPTEMBER 7, 2023

Following lengthy negotiations, the UK government has announced that the UK will be participating as a fully associated member of Horizon Europe for the remaining life of the programme to 2027. UK researchers can now apply for grants and bid to take part in projects under the Horizon programme.

Research 147

Research Government International Science 147

The Pharma Data

DECEMBER 16, 2020

(Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced an Advance Purchase Agreement with the government of New Zealand for the purchase of 10.7 million doses of NVX-CoV2373, Novavax’ candidate vaccine against COVID-19. About NVX-CoV2373.

Government 52

Government Vaccine Immune Response Clinical Trials 52

Drug Discovery World

NOVEMBER 7, 2023

The Commonwealth Government’s Medical Research Future Fund (MRFF) National Critical Research Infrastructure scheme will contribute $4.3 million, with Sanofi and UQ each committing $1 million, and the Queensland Government $250,000. “We aim to begin manufacturing mRNA for Phase I clinical trials in 2024.”

Clinical Trials 130

Clinical Trials Government Vaccine Laboratories 130

The Pharma Data

AUGUST 27, 2020

Moderna has announced that its coronavirus vaccine candidate has shown promise in generating an immune response in elderly patients in an early-stage clinical trial. . Each patient was given two 100 microgram doses of the vaccine 28 days apart. There is hope that Moderna’s vaccine could be available by early 2021. .

Vaccine 90

Vaccine Immune Response Clinical Trials Virus 90

BioPharma Drive: Drug Pricing

SEPTEMBER 28, 2023

In a note to clients, Evercore ISI analyst Jonathan Miller described the Project NextGen contract for Gritstone as “certainly a nice signal of continued government support for COVID research.”

Vaccine 103

Vaccine Government Research 103

Drug Discovery World

JUNE 26, 2023

Although the concept of using mRNA to make therapeutics or vaccines has been around for decades, it took the urgency of a global pandemic for it to become a reality. Now, there are many mRNA-based therapeutics in clinical development and mRNA cancer vaccines have been promised by 2030.

Vaccine 130

Vaccine Virus Clinical Trials Trials 130

The Pharma Data

NOVEMBER 17, 2021

Nasdaq VIR) moment blazoned US government contracts totalling roughly$ 1 billion (1) (USD) to buy sotrovimab, an investigational monoclonal antibody for the early treatment of COVID-19, which the US Food and Drug Administration (FDA) granted Exigency Use Authorization (EUA) in May 2021.

Government 52

Government Treatment Vaccine Compliance 52